companydata.dkcompanydata.dk

CLINICAL INNOVATION ApS: Financial statements 2020

CVR: 29924880

Source: annual report 2020, Danish Business Authority

01/10/2019 – 30/09/2020

CLINICAL INNOVATION ApS (CVR 29924880) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 3,946,000 and a net result of DKK 593,000 compared with DKK 15,000 the year before. That is an increase of 5.7% compared with the year before. Equity in the 2020 report amounted to DKK 3,567,000. The solvency ratio was 48.4%. The company had 7 employees in the financial year.

Gross Profit
DKK 3,946,000
Profit/Loss
DKK 593,000
Equity
DKK 3,567,000
Total Assets
DKK 7,369,000
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-3.9 mio.593 t.3.6 mio.7
2019-3.7 mio.15 t.3 mio.7
2018-4 mio.417 t.3.2 mio.7
2017-3.7 mio.243 t.3 mio.7000
2016-3.9 mio.754 t.2.9 mio.6000

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is CLINICAL INNOVATION ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

CLINICAL INNOVATION ApS: The 2019 annual report is outMar 11, 2020

CLINICAL INNOVATION ApS has published its annual report for 2019. Gross profit came to DKK 3,732,000, and the net result was DKK 15,000.

About CLINICAL INNOVATION ApS

CLINICAL INNOVATION ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Claus Michael Dinesen. The board consists of Ole Hedemann (chair), Claus Michael Dinesen, Magnus Oliver Lorentzen Dinesen and Marc Phillip Gall Schultz Lorentzen. The company is owned by PIA & CLAUS DINESEN HOLDING ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 2,775,826 and a net result of DKK 413,835 compared with DKK 95,746 the year before. Equity in the 2025 report amounted to DKK 3,821,950.

Source: annual report 2025, Danish Business Authority